Primary diffuse large B-cell lymphoma of the stomach

被引:76
作者
Ferreri, Andres J. M. [1 ]
Montalban, Carlos
机构
[1] Ist Sci San Raffaele, Med Oncol Unit, I-20132 Milan, Italy
[2] Hosp Ramon & Cajal, Med Interna Serv, E-28034 Madrid, Spain
关键词
B-cell lymphoma; Helicobacter pylori; rituximab; diffuse large B-cell lymphoma; staging; chemotherapy; radiotherapy;
D O I
10.1016/j.critrevonc.2007.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The stomach is the extranodal site most commonly involved by non-Hodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histotype category arising in this organ. This is an aggressive lymphoma usually presenting as limited disease, being associated or not to Helicobacter pylori infection and mucosa-associated lymphoid tissue-type areas. Histopathological characteristics are similar to those reported for other diffuse large B-cell lymphomas. It occurs more frequently in mates with a median age ranging between 50 and 60 years. With an adequate therapeutic strategy, its prognosis is good, with a 5-year overall survival near to 90%. Conservative treatment with anthracycline-containing chemotherapy, followed or not by involved-field radiotherapy has replaced gastrectomy as standard approach against this malignancy. Several questions on the best treatment remain unanswered. Among others, the role of rituximab, consolidation radiotherapy as well as of more conservative approaches like H. pylori-eradicating antibiotic therapy should be better defined. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 64 条
[21]  
FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
[22]  
2-#
[23]  
Godlewski G, 1997, J CHIR-PARIS, V134, P438
[24]   INTERMEDIATE AND HIGH-GRADE GASTRIC NON-HODGKINS-LYMPHOMA - A PROSPECTIVE-STUDY OF NONSURGICAL TREATMENT WITH PRIMARY CHEMOTHERAPY, WITH OR WITHOUT RADIOTHERAPY [J].
HAIM, N ;
LEVIOV, M ;
BENARIEH, Y ;
EPELBAUM, R ;
FREIDIN, N ;
RESHEF, R ;
BENSHAHAR, M .
LEUKEMIA & LYMPHOMA, 1995, 17 (3-4) :321-326
[25]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[26]   THE RESPONSE OF CELLS FROM LOW-GRADE B-CELL GASTRIC LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TO HELICOBACTER-PYLORI [J].
HUSSELL, T ;
ISAACSON, PG ;
CRABTREE, JE ;
SPENCER, J .
LANCET, 1993, 342 (8871) :571-574
[27]   Primary gastric non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma [J].
Ibrahim, EM ;
Ezzat, AA ;
Raja, MA ;
Rahal, MM ;
Ajarim, DS ;
Mann, B ;
Baloush, A ;
Stuart, RK ;
Bazarbashi, SN .
ANNALS OF ONCOLOGY, 1999, 10 (12) :1441-1449
[28]   Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach [J].
Ishikura, S ;
Tobinai, K ;
Ohtsu, A ;
Nakamura, S ;
Yoshino, T ;
Oda, I ;
Takagi, T ;
Mera, K ;
Kagami, Y ;
Itoh, K ;
Tamaki, Y ;
Suzumiya, J ;
Taniwaki, M ;
Yamamoto, S .
CANCER SCIENCE, 2005, 96 (06) :349-352
[29]   Primary gastrointestinal non-Hodgkin's lymphoma:: II.: Combined surgical and conservative or conservative management only in localized gastric lymphoma -: Results of the Prospective German Multicenter Study GIT NHL 01/92 [J].
Koch, P ;
del Valle, F ;
Berdel, WE ;
Willich, NA ;
Reers, B ;
Hiddemann, W ;
Grothaus-Pinke, B ;
Reinartz, G ;
Brockmann, J ;
Temmesfeld, A ;
Schmitz, R ;
Rübe, C ;
Probst, A ;
Jaenke, G ;
Bodenstein, H ;
Junker, A ;
Pott, C ;
Schultze, J ;
Heinecke, A ;
Parwaresch, R ;
Tiemann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3874-3883
[30]   Treatment results in localized primary gastric lymphoma: Data of patients registered within the German Multicenter Study (GIT NHL 02/96) [J].
Koch, P ;
Probst, A ;
Berdel, WE ;
Willich, NA ;
Reinartz, G ;
Brockmann, J ;
Liersch, R ;
del Valle, F ;
Clasen, H ;
Hirt, C ;
Breitsprecher, R ;
Schmits, R ;
Freund, M ;
Fietkau, R ;
Ketterer, P ;
Freitag, EM ;
Hinkelbein, M ;
Heinecke, A ;
Parwaresch, R ;
Tiemann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :7050-7059